MedTech News
.................... by Andrew Celentano

QT Imaging secures FDA clearance for updated Breast Acoustic CT scanner
The scanner reconstructs 3D tomographic images by utilising both reflection-mode and transmission-mode ultrasound data.

Smith+Nephew unveils foam dressing for pressure injury prevention
The dressing combines several technologies to minimise leakage, reduce dressing changes, and protect vulnerable skin.

Karl Storz wins FDA nod for single-use bronchoscope
Karl Storz announced that it received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope.

New cancer therapies target epigenetic switch
Now researchers in the former Laboratory of Chromatin Biology and Epigenetics, headed by C. David Allis until his death in early 2023, have discovered surprising new details about the mechanics of this protein complex, which could potentially lead to new cancer therapies. The findings were published in Genes & Development.

A 3D printable scaffold to support fast bone growth
Researchers in the Soft Materials Laboratory (SMaL) in EPFL’s School of Engineering have now developed a way to 3D-print HA-based scaffolds using a room-temperature process that harnesses enzymes for fast mineralization.

Dynamic gel helps scientists grow organs more reliably in the lab
Miniature organs grown in the lab can organize themselves into complex shapes. But they never do it the same way twice, which makes it hard to use these so-called “organoids” to study disease. Now, scientists at UC San Francisco have created a new material that helps organoids grow in a more predictable way.

Spinal stimulation above and below injury restores leg movement and sensory feedback in clinical trial
Now, a team of researchers from Brown University, Rhode Island Hospital, and VA Providence Healthcare has shown progress in restoring two-way communication across a damaged site of the spinal cord.

Unusual tumor cells may be overlooked factors in advanced breast cancer
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.